InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,949.17
(
-0.60%
)
US TECH 100
20,308.00
(
-0.89%
)
Dow Jones
43,750.86
(
-0.47%
)
Brent Oil
72.21
(
0.48%
)
Bitcoin
87,436.91
(
-3.45%
)
Post# of 29664
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

mr_o

Send PM Follow Ignore
Followers 10
Posts 354
Boards Moderated 0
Alias Born 07/03/2013

mr_o

Re: DewDiligence post# 23521

Sunday, 02/07/2021 7:51:46 PM

Sunday, February 07, 2021 7:51:46 PM

Post# of 29664
All things considered PCVX did alright valuation wise. Still pre-clinical and valued at 1.2 billion. If PCVX can prove out VAX-24 safety and efficacy and quickly follow up with VAX-30+, PCVX may have a better strategic position. Thanks for the PCVX discussion.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up